Cancer gene therapy by thyroid hormone-mediated expression of toxin genes

Cancer Research

Volumn 60, Issue 12, 2000, Pages 3218-3224

  Martín, Verónica ^a   Cortés, Maria Luisa ^a   De Felipe, Pablo ^a   Farsetti, Antonella ^b   Calcaterra, Nora B ^c   Izquierdo, Marta ^a  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; MYELIN BASIC PROTEIN; PRODRUG; PSEUDOMONAS EXOTOXIN; RICIN; THYROID HORMONE;

ANIMAL CELL; ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; CYTOTOXICITY; GENE AMPLIFICATION; GENE EXPRESSION; GENE THERAPY; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; RETROVIRUS;

ANIMALS; BRAIN NEOPLASMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; GLIOBLASTOMA; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED BALB C; MICE, SCID; MYELIN BASIC PROTEINS; NEOPLASM TRANSPLANTATION; PLASMIDS; PROMOTER REGIONS (GENETICS); RATS; RATS, WISTAR; RETROVIRIDAE; RICIN; THYROID HORMONES; TOXINS, BIOLOGICAL; TRANSFECTION;

EID: 0034123875     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Culver, K. W., Wallbridge, S., Ishii, H., Oldfield, E. H., and Blaese, R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (Washington DC), 256: 1550-1552, 1992.
2. Ram, Z., Culver, K. W., Wallbridge, S., Frank, J. A., Blaese, E. H., and Oldfield, E. H. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res., 53: 83-88, 1993.
3. Izquierdo, M., Cortés, M. L., de Felipe, P., Martín, V., Diez-Guerra, J., Talavera, A., and Pérez-Higueras, A. Long-term rat survival after malignant brain tumor regression by retroviral gene therapy. Gene Ther., 2: 66-69, 1995.
4. Izquierdo, M., Cortés, M. L., Martín, V., de Felipe, P., Izquierdo, J. M., Pérez-Higueras, A., Paz, J. F., Isla, A., and Blázquez, M. G. Implications of the size of glioblastoma on its curability. Acta Neurochir. Suppl., 68: 111-117, 1997.
5. Culver, K., Van Gilder, J., Link, C. J., Carlstrom, T., Buroker, T., Yuh, W., Koch, K., Schabold, K., Doornbas, S., Wetjen, B., and Blaise, R. M. Gene therapy for the treatment of malignant brain tumors with in vivo tumor transduction with herpes simplex thymidine kinase gene/ganciclovir system. Hum. Gene Ther., 5: 343-379, 1994.
6. Izquierdo, M., Martín, V., de Felipe, P., Izquierdo, J. M., Pérez-Higueras, A., Cortés, M. L., Paz, J. F., Isla, A., and Blázquez, M. G. Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy. Gene Ther., 3: 491-495, 1996.
7. Ram, Z., Culver, K. W., Oshiro, E. M., Viola, J. J., De Vroom, H. L., Otto, E., Long, Z., Chiang, Y., McGarrity, G. J., Muul, L. M., Katz, D., Blaese, R. M., and Oldfield, E. H. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat. Med., 3: 1354-1361, 1997.
8. Manome, Y., Wen, P. Y., Dong, Y., Tanaka, T., Mitchell, B. S., Kuf, D. W., and Fine, H. A. Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of 1-β-D-arabinofuranosylcytosine in vitro and in vivo. Nat. Med., 2: 567-573, 1996.
9. Cortés, M. L., de Felipe, P., Martín, V., Hughes, M., and Izquierdo, M. Successful use of a plant gene in the treatment of cancer in vivo. Gene Ther., 5: 1499-1507, 1998.
10. Spear, M. T. Gene therapy of gliomas: receptor and transcriptional targeting. Anticancer Res., 18: 3223-3232, 1998.
11. Miskimis, R., Knapp, L., Dewey, M. J., and Zhang, X. Cell and tissue-specific expression of a heterologous gene under control of the myelin basic protein gene promoter in transgenic mice. Dev. Brain Res., 65: 217-221, 1992.
12. Miyao, Y., Shimizu, K., Moriuchi, S., Yamada, M., Nakahira, K., Nakajima, K., Nakao, J., Kuriyama, S., Tsujii, T., and Mikoshiba, K. Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression. J. Neurosci. Res., 36: 472-479, 1993.
13. Kimura, M., Sato, M., Akatsuka, A., Nozawa-Kimura, S., Takahashi, R., Yokoyama, M., Nomura, T., and Katsuki, M. Restoration of myelin formation by a single type of myelin basic protein in transgenic shiverer mice. Proc. Natl. Acad. Sci. USA, 86: 5661-5665, 1989.
14. Readhead, C., Popko, B., Takahashi, N., Shine, H. D., Saavedra, R. A., Sidman, R. L., and Hood, L. Expression of a myelin basic protein gene in transgenic shiverer mice: correction of the dysmyelinating phenotype. Cell, 48: 703-712, 1987.
15. Ikenaka, K., Nakahira, K., Nakajima, K., Fujimoto, I., Kajawa, T., Ogawa, M., and Miloshiba, K. Detection of brain-specific gene expression in brain cells in primary culture: a novel promoter assay based on the use of a retrovirus vector. New Biol., 4: 53-60, 1992.
16. Chen, H., McCarty, D. M., Bruce, A. T., Suzuki, K., and Suzuki, K. Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adeno-associated virus. Gene Ther., 5: 50-58, 1998.
17. Farsetti, A., Mitsuhashi, T., Desvergne, B., Robins, J., and Nikodem, V. M. Molecular basis of thyroid hormone regulation of myelin basic protein gene expression in rodent brain. J. Biol. Chem., 266: 23226-23232, 1991.
18. Miura, M., Tamura, T., Aoyama, A., and Mikoshiba, K. The promoter elements of the mouse myelin basic protein gene function efficiently in NG108-15 neuronal/glial cells. Gene (Amst.), 75: 31-38, 1989.
19. Asipu, A., and Blair, G. E. Regulation of myelin basic protein-encoding gene transcription in rat oligodendrocytes. Gene (Amst.), 150: 227-234, 1994.
20. Farsetti, A., Desvergne, B., Hallenbeck, P., Robins, J., and Nikodem, V. M. Characterization of myelin basic protein thyroid hormone response element and its function in the context of native and heterologous promoter. J. Biol. Chem., 267: 15784-15788, 1992.
21. Samuels, H. H., Stanley, F., and Casanova, J. Depletion of L-3,5,3′-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology, 105: 80-85, 1979.
22. de Felipe, P., Martín, V., Cortés, M. L., Ryan, M., and Izquierdo, M. Use of the 2A sequence from foot-and-mouse disease virus in the generation of retroviral vectors for gene therapy. Gene Ther., 6: 198-208, 1999.
23. Lamb, F. I., Roberts, L. M., and Lord, J. M. Nucleotide sequence of cloned cDNA coding for preproncin. Eur. J. Biochem., 148: 265-270, 1985.
24. Gray, G. L., Smith, D. H., Baldridge, J. S., Harkins, R. N., Vasil, M. L., Chen, E. Y., and Heyneker, H. L. Cloning, nucleotide sequence, and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA, 81: 2645-2649, 1984.
25. Murray, M. B., Zilz, N. D., McCreay, N. L., McDonald, M. J., and Toyle, H. C. Isolation and characterization of rat cDNA clones for two distinct thyroid hormone receptors. J. Biol. Chem., 263: 12770-12777, 1988.
26. Miller, D., and Rosman, G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques, 7: 980-988, 1989.
27. Hafkemeyer, P., Brinkmann, U., Gottesman, M., and Pastan, I. Apoptosis induced by Pseudomonas exotoxin: a sensitive and rapid marker for gene delivery in vivo. Hum. Gene Ther., 10: 923-934, 1999.
28. Brinkmann, U., and Pastan, I. Immunotoxins against cancer. Biochim. Biophys. Acta, 1198: 27-45, 1994.
29. Miller, A. D. Human gene therapy comes of age. Nature (Lond.), 357: 455-460, 1992.
30. Mann, R., Mulligan, R. C., and Baltimore, D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell, 33: 153-159, 1983.
31. Culver, K. W. Clinical applications of gene therapy for cancer. Clin. Chem, 40: 510-512, 1994.
32. Crystal, R. G. Transfer of genes to humans: early lessons and obstacles to success. Science (Washington DC), 270: 404-410, 1995.
33. Jeannin, E., Robyr, D., and Desvergne, B. Transcriptional regulatory patterns of the myelin basic protein and malic enzyme genes by the thyroid hormone receptors α 1 and β 1. J. Biol. Chem., 273: 24239-24248, 1998.
34. Ackland-Berglund, C. E., and Leib, D. A. Efficacy of tetracycline-controlled gene expression is influenced by cell type. Biotechniques, 18: 196-200, 1995.
35. Howe, J. R., Skryabin, B. V., Belcher, S. M., Zerillo, C. A., and Schmauss, C. The responsiveness of a tetracycline-sensitive expression system differs in different cell lines. J. Biol. Chem., 270: 14168-14174, 1995.
36. Lu, B., and Federoff, H. Herpes simplex virus type 1 amplicon vectors with glucocorticoid-inducible gene expression. Hum. Gene Ther., 6: 419-428, 1995.
37. Koh, G. Y., Kim, S. J., Klug, M. G., Soonpaa, M. H., and Fiel, L. J. Targeted expression of transforming growth factor-β1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J. Clin. Investig., 95: 114-121, 1995.
38. Smith, J. D., Wong, E., and Ginsberg, M. Cytochrome P450 1A1 promoter as a genetic switch for the regulatable and physiological expression of a plasma protein in transgenic mice. Proc. Natl. Acad. Sci. USA, 92: 11926-11930, 1995.